- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Aquired resistance to EGFR TKI
Total 476887 results
-
University of California, San DiegoEli Lilly and CompanyActive, not recruitingLung CancerUnited States
-
AstraZenecaCompletedLocally Advanced or Metastatic EGFR T790M+ NSCLCCanada, Korea, Republic of, Taiwan
-
Laibin People's HospitalCompletedThe Primary Study Metric is Progression-free Survival (PFS)
-
Novartis PharmaceuticalsTerminatedNon Small Cell Lung CancerCanada, Spain, Australia, Singapore, Germany, Italy, Korea, Republic of, Norway, Taiwan, United States, France
-
Blueprint Medicines CorporationTerminatedNeoplasms | Respiratory Tract Diseases | Neoplasms by Histologic Type | Lung Diseases | Neoplasms by Site | Adenocarcinoma | Carcinoma | Carcinoma, Non-Small-Cell Lung | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Bronchial Neoplasms | Neoplasms, Nerve Tissue | Non Small Cell Lung... and other conditionsUnited States
-
Massachusetts General HospitalNovartisActive, not recruitingLung CancerUnited States
-
Boehringer IngelheimCompletedNon-squamous, Non-Small Cell Lung CancerUnited Kingdom
-
AbbVieRadiation Therapy Oncology GroupCompletedGlioblastoma | GliosarcomaUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Colombia, Czechia, France, Germany, Hong Kong, Ireland, Israel, Italy, Korea, Republic of, Mexico, Netherlands, New Zealand, Portugal, Russian Federation, Singapor... and more
-
Oslo University HospitalAstraZenecaActive, not recruitingLung Cancer | Targeted TherapySweden, Finland, Denmark, Lithuania, Norway
-
First Affiliated Hospital of Zhejiang UniversityTerminatedNon Small Cell Lung CancerChina
-
The Netherlands Cancer InstituteRoche Pharma AG; AstraZenecaTerminatedCarcinoma, Non-Small-Cell LungNetherlands
-
University of Colorado, DenverInivataWithdrawnNon-Small Cell Lung CancerUnited States
-
Fondazione del Piemonte per l'OncologiaCompleted
-
ETOP IBCSG Partners FoundationHoffmann-La Roche; AstraZenecaActive, not recruitingNon Small Cell Lung Cancer MetastaticIreland, Singapore, Spain, Switzerland, Korea, Republic of, Netherlands
-
National Taiwan University HospitalCompletedTumor Progression | EGFR Exon 19 MutationTaiwan
-
Instituto Oncológico Dr RosellMFAR; Bioven EuropeCompletedCarcinoma, Non-Small-Cell LungSpain
-
National Cancer Center, KoreaHoffmann-La RocheActive, not recruitingNSCLC Stage II | NSCLC, Stage IIIAKorea, Republic of
-
Fudan UniversityCompletedNasopharyngeal CarcinomaChina
-
China Medical University HospitalCompletedAdvanced Lung Adenocarcinoma
-
Shanghai Pharmaceuticals Holding Co., LtdWithdrawn
-
Samsung Medical CenterActive, not recruitingNon-Small Cell Lung Cancer With EGFR T790M Mutation | With Brain and/or Leptomeningeal Metastasis | Failed Tyrosine Kinase InhibitorsKorea, Republic of
-
Sun Yat-sen UniversityCompletedNon-small Cell Lung CancerChina
-
Sichuan Provincial People's HospitalTerminatedStage IV EGFR Mutated Non-Small Cell Lung CancerChina
-
Hanmi Pharmaceutical Company LimitedTerminatedNon Small Cell Lung CancerUnited States, Australia, Italy, Korea, Republic of, Spain, Germany, Malaysia, Taiwan, Canada, Philippines
-
UNC Lineberger Comprehensive Cancer CenterAstellas Pharma Global Development, Inc.CompletedNon Small Cell Lung CancerUnited States
-
AstraZenecaCompleted
-
University Health Network, TorontoNovartisCompletedChronic Phase Chronic Myeloid Leukemia | Philadelphia Positive Acute Lymphoblastic Leukemia | Accelerated Phase Chronic Myeloid Leukemia | Blastic Phase Chronic Myeloid Leukemia | Resistant to Tyrosine Kinase Inhibitor TherapyCanada
-
PfizerCompletedSolid Tumor | Unspecified Adult Solid Tumor, Protocol SpecificUnited States, Australia, Canada, France, Spain
-
Array Biopharma, now a wholly owned subsidiary...CompletedAdvanced Solid Tumors | Selected Solid TumorsUnited States, Germany, Canada, Spain, Netherlands, Singapore, Switzerland
-
Shanghai Cancer Hospital, ChinaUnknownLung Cancer Stage IV,EGFR-mutant,TKI,PD-L1,SBRTChina
-
Hanmi Pharmaceutical Company LimitedTerminatedNon Small Cell Lung CancerKorea, Republic of
-
First Hospital of Shijiazhuang CityTianjin Hengjia Biotechnology Development co., LTDUnknownNon Small Cell Lung CancerChina
-
Ahon Pharmaceutical Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical SciencesUnknown
-
Sun Yat-sen UniversityCompletedColorectal CancerChina
-
Chinese University of Hong KongPamela Youde Nethersole Eastern HospitalCompleted
-
Fuda Cancer Hospital, GuangzhouCompletedLung Neoplasms
-
Second Affiliated Hospital of Nanchang UniversityNanchang UniversityUnknownNon-small Cell Lung Cancer | EGFR Gene MutationChina
-
Cancer Institute and Hospital, Chinese Academy...UnknownNon Small Cell Lung Cancer | Stage III Non-small-cell Lung Cancer | EGFR Mutation-Related Tumors
-
Novartis PharmaceuticalsTerminatedNon-Small Cell Lung CancerItaly, Singapore, Spain, Germany, Korea, Republic of, United States, Belgium, France, Netherlands, Japan
-
Guangdong Association of Clinical TrialsUnknownNon-small Cell Lung CancerChina
-
Astellas Pharma Global Development, Inc.CompletedNon-Small-Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor MutationsUnited States
-
AstraZenecaMedpace, Inc.CompletedNon-small Cell Lung CancerUnited States, Canada
-
Astellas Pharma IncTerminatedNon-small Cell Lung CancerJapan, Korea, Republic of, Taiwan
-
Shanghai Chest HospitalCompletedLung Adenocarcinoma | EGFR Activating Mutation
-
Baodong QinUnknownNSCLC Stage IV | Anlotinib | EGFR T790M-negative | JS001China
-
Clovis Oncology, Inc.TerminatedNon-small Cell Lung CancerKorea, Republic of, United States, France, Germany, Netherlands, Australia, Spain, Taiwan, United Kingdom, Italy
-
Novartis PharmaceuticalsTerminatedAdvanced Non Small Cell Lung Cancer (NSCLC)France, Italy, Taiwan, Spain, Netherlands, Japan, Hong Kong, Korea, Republic of, Norway, United States, United Kingdom, Poland
-
Cancer Institute and Hospital, Chinese Academy...UnknownNon-Small Cell Lung Cancer MetastaticChina
-
Betta Pharmaceuticals Co., Ltd.UnknownNon-small Cell Lung Cancer | Brain MetastasesChina
-
Hangzhou ACEA Pharmaceutical Research Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical SciencesWithdrawn